CHAMPIONS ONCOLOGY, INC. Noncash or Part Noncash Acquisition, Fixed Assets Acquired
CHAMPIONS ONCOLOGY, INC. (CSBR) reported Noncash or Part Noncash Acquisition, Fixed Assets Acquired of $0 for the 9-month period ending 2021-01-31, per its 10-Q filed 2021-03-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 · last filed 2021-03-15
- CHAMPIONS ONCOLOGY, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2021-01-31 was $0.00.
- CHAMPIONS ONCOLOGY, INC. noncash or part noncash acquisition, fixed assets acquired for the quarter ending 2020-01-31 was $0.00.
| Period end | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 3 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 6 month | Noncash or Part Noncash Acquisition, Fixed Assets Acquired 9 month |
|---|---|---|---|
| 2021-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | $0.00 10-Q · filed 2021-03-15 | |
| 2020-10-31 | $0.00 10-Q · filed 2020-12-14 | ||
| 2020-01-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-03-15 | $160.00K 10-Q · filed 2021-03-15 | |
| 2019-10-31 | $160.00K 10-Q · filed 2020-12-14 | ||
| 2018-10-31 | $0.00 10-Q · filed 2019-12-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |